Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04478942 · ClinicalTrials.gov registry record · Early Phase 1
PROMMO Trial: Oral Misoprostol vs IV Oxytocin
A Early Phase 1 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 138
- Enrollment target
NCT04478942 is a Early Phase 1 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 138 participants.
The verdict
NCT04478942, a Early Phase 1 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 138 participants
- Enrollment target
Study Summary
This is a prospective, randomized trial looking at the ideal method of labor induction for women with prelabor rupture of membranes and an unfavorable cervical Bishop score. The study will compare oral misoprostol and intravenous oxytocin.
Interventions
- DRUG Misoprostol Oral Product
- DRUG Intravenous Oxytocin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 138 participants |
| Start Date | 2020-10-26 |
| Est. Completion | 2025-01-14 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04478942
The ClinicalTrials.gov registry entry for NCT04478942 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 138 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Misoprostol Oral Product is the first listed.
NCT04478942 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04478942 about?
NCT04478942 is a clinical study titled "PROMMO Trial: Oral Misoprostol vs IV Oxytocin". This is a prospective, randomized trial looking at the ideal method of labor induction for women with prelabor rupture of membranes and an unfavorable cervical Bishop score. The study will compare oral misoprostol and intravenous oxytocin.
What is the current status of trial NCT04478942?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 138 participants. The study started on 2020-10-26. Estimated completion is 2025-01-14.
What interventions are being tested in trial NCT04478942?
The interventions under investigation include: Misoprostol Oral Product (DRUG), Intravenous Oxytocin (DRUG).
Who is sponsoring clinical trial NCT04478942?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.